Tags

Type your tag names separated by a space and hit enter

Folate and vitamin B12 may play a critical role in lowering the HPV 16 methylation-associated risk of developing higher grades of CIN.
Cancer Prev Res (Phila) 2014; 7(11):1128-37CP

Abstract

We previously reported that a higher degree of methylation of CpG sites in the promoter (positions 31, 37, 43, 52, and 58) and enhancer site 7862 of human papillomavirus (HPV) 16 was associated with a lower likelihood of being diagnosed with HPV 16-associated CIN 2+. The purpose of this study was to replicate our previous findings and, in addition, to evaluate the influence of plasma concentrations of folate and vitamin B12 on the degree of HPV 16 methylation (HPV 16m). The study included 315 HPV 16-positive women diagnosed with either CIN 2+ or ≤CIN 1. Pyrosequencing technology was used to quantify the degree of HPV 16m. We reproduced the previously reported inverse association between HPV 16m and risk of being diagnosed with CIN 2+. In addition, we observed that women with higher plasma folate and HPV 16m or those with higher plasma vitamin B12 and HPV 16m were 75% (P < 0.01) and 60% (P = 0.02) less likely to be diagnosed with CIN 2+, respectively. With a tertile increase in the plasma folate or vitamin B12, there was a 50% (P = 0.03) and 40% (P = 0.07) increase in the odds of having a higher degree of HPV 16m, respectively. This study provides initial evidence that methyl donor micronutrients, folate and vitamin B12, may play an important role in maintaining a desirably high degree of methylation at specific CpG sites in the HPV E6 promoter and enhancer that are associated with the likelihood of being diagnosed with CIN 2+.

Authors+Show Affiliations

Department of Nutrition Sciences, University of Alabama at Birmingham, Birmingham, Alabama. piyathic@uab.edu.University of Cincinnati College of Medicine, Cincinnati, Ohio.Department of Nutrition Sciences, University of Alabama at Birmingham, Birmingham, Alabama.Department of Nutrition Sciences, University of Alabama at Birmingham, Birmingham, Alabama.Department of Nutrition Sciences, University of Alabama at Birmingham, Birmingham, Alabama.Department of Pathology, University of Alabama at Birmingham, Birmingham, Alabama.Department of Medicine, University of Alabama at Birmingham, Birmingham, Alabama.University of Alabama at Birmingham Comprehensive Cancer Center, Birmingham, Alabama.Department of Obstetrics & Gynecology, University of Alabama at Birmingham, Birmingham, Alabama.Department of Veterinary Sciences, The University of Texas MD Anderson Cancer Center, Houston, Texas and SRI International, Menlo Park, CA.

Pub Type(s)

Journal Article
Research Support, N.I.H., Extramural

Language

eng

PubMed ID

25145486

Citation

Piyathilake, Chandrika J., et al. "Folate and Vitamin B12 May Play a Critical Role in Lowering the HPV 16 Methylation-associated Risk of Developing Higher Grades of CIN." Cancer Prevention Research (Philadelphia, Pa.), vol. 7, no. 11, 2014, pp. 1128-37.
Piyathilake CJ, Macaluso M, Chambers MM, et al. Folate and vitamin B12 may play a critical role in lowering the HPV 16 methylation-associated risk of developing higher grades of CIN. Cancer Prev Res (Phila). 2014;7(11):1128-37.
Piyathilake, C. J., Macaluso, M., Chambers, M. M., Badiga, S., Siddiqui, N. R., Bell, W. C., ... Johanning, G. L. (2014). Folate and vitamin B12 may play a critical role in lowering the HPV 16 methylation-associated risk of developing higher grades of CIN. Cancer Prevention Research (Philadelphia, Pa.), 7(11), pp. 1128-37. doi:10.1158/1940-6207.CAPR-14-0143.
Piyathilake CJ, et al. Folate and Vitamin B12 May Play a Critical Role in Lowering the HPV 16 Methylation-associated Risk of Developing Higher Grades of CIN. Cancer Prev Res (Phila). 2014;7(11):1128-37. PubMed PMID: 25145486.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - Folate and vitamin B12 may play a critical role in lowering the HPV 16 methylation-associated risk of developing higher grades of CIN. AU - Piyathilake,Chandrika J, AU - Macaluso,Maurizio, AU - Chambers,Michelle M, AU - Badiga,Suguna, AU - Siddiqui,Nuzhat R, AU - Bell,Walter C, AU - Edberg,Jeffrey C, AU - Partridge,Edward E, AU - Alvarez,Ronald D, AU - Johanning,Gary L, Y1 - 2014/08/21/ PY - 2014/8/23/entrez PY - 2014/8/26/pubmed PY - 2015/7/24/medline SP - 1128 EP - 37 JF - Cancer prevention research (Philadelphia, Pa.) JO - Cancer Prev Res (Phila) VL - 7 IS - 11 N2 - We previously reported that a higher degree of methylation of CpG sites in the promoter (positions 31, 37, 43, 52, and 58) and enhancer site 7862 of human papillomavirus (HPV) 16 was associated with a lower likelihood of being diagnosed with HPV 16-associated CIN 2+. The purpose of this study was to replicate our previous findings and, in addition, to evaluate the influence of plasma concentrations of folate and vitamin B12 on the degree of HPV 16 methylation (HPV 16m). The study included 315 HPV 16-positive women diagnosed with either CIN 2+ or ≤CIN 1. Pyrosequencing technology was used to quantify the degree of HPV 16m. We reproduced the previously reported inverse association between HPV 16m and risk of being diagnosed with CIN 2+. In addition, we observed that women with higher plasma folate and HPV 16m or those with higher plasma vitamin B12 and HPV 16m were 75% (P < 0.01) and 60% (P = 0.02) less likely to be diagnosed with CIN 2+, respectively. With a tertile increase in the plasma folate or vitamin B12, there was a 50% (P = 0.03) and 40% (P = 0.07) increase in the odds of having a higher degree of HPV 16m, respectively. This study provides initial evidence that methyl donor micronutrients, folate and vitamin B12, may play an important role in maintaining a desirably high degree of methylation at specific CpG sites in the HPV E6 promoter and enhancer that are associated with the likelihood of being diagnosed with CIN 2+. SN - 1940-6215 UR - http://www.unboundmedicine.com/medline/citation/25145486/full_citation L2 - http://cancerpreventionresearch.aacrjournals.org/cgi/pmidlookup?view=long&amp;pmid=25145486 DB - PRIME DP - Unbound Medicine ER -